A Patient Decision Aid for Method of Early Abortion: a Randomized Control Trial
1 other identifier
interventional
365
1 country
1
Brief Summary
Introduction: There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. When making a decision about which option is best for them, patient must consider their values as well as social resources and circumstances Patient decision aids (PtDAs) are tools to help patients make health-related decisions, particularly when no 'best' choice exist. Our research team has developed an online interactive patient decision aid on method of abortion based on international standards for decision aid development. We would like to investigate whether it leads to improved decisional quality in patients seeking early abortion. Methods: Phase 1 will be development of an abortion knowledge assessment tool. We will start by developing ten multiple choice questions based on information that is classically included in abortion education material. The goal is to ultimately include 5-7 well-performing questions in the trial. The ten questions will be sent to content experts to answer and rate. They will rate the questions on representativeness and importance. The questions will also be administered to community members without specific abortion knowledge. Results will be used to assess content validity and discriminator validity and revise the questionnaire. Phase 2 will be a randomized trial of people seeking abortion at less than 63 days gestation. Those who wish to participate will be randomized either the decision aid (study group) or the standard abortion clinic website (control). They will then be asked to participate in a survey immediately after they are finished reviewing the decision aid or website to. This survey will include questions about their decision, demographics, medical history, and their level of knowledge about abortion methods (by administering the knowledge assessment tool described above). The evaluation of the decision making will be measured using the Decisional Conflict Score. Four weeks post procedure, participants will be contacted by e-mail again and asked to complete a second survey identifying which type of abortion they underwent along with an inventory of perceived adverse treatment effects, as well as completing a Satisfaction with Decision Scale (SWD)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2021
CompletedFirst Posted
Study publicly available on registry
January 10, 2022
CompletedStudy Start
First participant enrolled
May 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedFebruary 21, 2025
February 1, 2025
1.8 years
December 12, 2021
February 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decisional Conflict Score
The DCS consists of 16 statements that participants rate from "strongly agree" \[0\] to "strongly disagree" \[4\]; scores are summed, divided by 16, and multiplied by 25 (for a score out of 100). High scores indicate greater decisional conflict.
Immediately after use of intervention (decision aid) or usual care condition (clinic website)
Secondary Outcomes (3)
Satisfaction with decision score (SWD)
4 weeks after enrolment (after abortion complete)
Decision concordance
4 weeks after enrolment (after abortion complete)
Knowledge of abortion method score
Immediately after use of intervention (decision aid) or usual care condition (clinic website)
Other Outcomes (1)
Correlation between SWD scores and patient reported side effects
4 weeks after enrolment (after abortion complete)
Study Arms (2)
Decision Aid
EXPERIMENTALPatients will be guided to an online interactive decision aid tool.
Usual Care
ACTIVE COMPARATORPatients will be guided to visit the clinic website of the Nova Scotia Women's Choice Clinic.
Interventions
Eligibility Criteria
You may qualify if:
- person of reproductive age seeking termination of pregnancy, felt to be within the eligible period for a medication abortion (\<9 weeks or 63 days from last menstrual period), can provide consent, has access to internet and a valid email address and be able to read and speak English.
You may not qualify if:
- Participants will be excluded from the four week follow up survey if they are subsequently found to be ineligible for medication abortion (pregnancy too advanced or if there are medical contraindications), if they miscarry spontaneously, or choose to continue their pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nova Scotia Health Authoritylead
- Dalhousie Universitycollaborator
- University of British Columbiacollaborator
- IWK Health Centrecollaborator
Study Sites (1)
QEII Health Sciences Center
Halifax, Nova Scotia, B3H 2Y9, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa Brooks
Dalhousie University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Obgyn
Study Record Dates
First Submitted
December 12, 2021
First Posted
January 10, 2022
Study Start
May 5, 2022
Primary Completion
March 1, 2024
Study Completion
April 1, 2024
Last Updated
February 21, 2025
Record last verified: 2025-02